TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Canopy Growth CEO Outlines Cannabis Disruption Still to Come
REGULATION

Canopy Growth's Bruce Linton Outlines the Cannabis Disruption Still to Come

  • By Kevin Curran
  • Nov 29, 2018 1:40 PM EST
PRESS RELEASES

Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Raul Elizalde Invited To Speak On Expert Panel About Cannabis In Mexico

  • By PR Newswire
  • Jun 23, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited To Speak At The Global Cannabis Summit Virtual Conference

  • By PR Newswire
  • Jun 11, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey To Board Of Advisors

  • By PR Newswire
  • Jun 4, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division And Announces Dr. Sergei Svarovsky As Chief Scientific Officer Of Subsidiary Sapphire Biotech

  • By PR Newswire
  • May 28, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent For Unique Early Detection Cancer Biomarker

  • By PR Newswire
  • May 21, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. And Subsidiaries Kannaway® And HempMeds® Honored As Stevie® Award Winners In 2020 American Business Awards®

  • By PR Newswire
  • May 19, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-Ever CBD Fitness Program

  • By PR Newswire
  • May 11, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Names Caroline Heinz And Raul Elizalde Co-CEOs Of Subsidiary HempMeds®, Appoints Todd Morrow To Chief Information Officer

  • By PR Newswire
  • May 7, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application For Water-Soluble Cannabinoid Molecules

  • By PR Newswire
  • May 5, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Largest Digital Event In Company History

  • By PR Newswire
  • Apr 30, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen To Company's Managing Director Of International

  • By PR Newswire
  • Apr 22, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones To President

  • By PR Newswire
  • Apr 14, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice Of Allowance From USPTO For Trademark Of Atopidine™

  • By PR Newswire
  • Apr 9, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. CEO Featured In U.S. News And World Report Providing Insight On Penny Stocks

  • By PR Newswire
  • Apr 2, 2020 9:00 AM EDT
PRESS RELEASES

HempMeds®, Subsidiary Of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line With Two New Flavors

  • By PR Newswire
  • Mar 31, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. CEO Featured In Reuters Coverage Highlighting The Impact Of COVID-19 On Cannabis Industry

  • By PR Newswire
  • Mar 26, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition Of Oncology Research And Development Company Sapphire Biotech, Inc.

  • By PR Newswire
  • Mar 24, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Portfolio Of Companies Celebrates $2 Million Milestone In CBD Product Donations To Non-Profit Organization ECHO Connection

  • By PR Newswire
  • Mar 12, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Subsidiary Kannaway® Launches New Hemp Calm CBD Oral Applicator In Europe

  • By PR Newswire
  • Mar 10, 2020 9:00 AM EDT
PRESS RELEASES

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent In The European Union (EU)

  • By PR Newswire
  • Mar 5, 2020 9:00 AM EST
PRESS RELEASES

HempMeds®, Subsidiary Of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation Of Its Active Relief Roll-On Topical

  • By PR Newswire
  • Feb 27, 2020 9:00 AM EST
PRESS RELEASES

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors Autism Event At Rice University In Houston

  • By PR Newswire
  • Feb 25, 2020 9:00 AM EST
PRESS RELEASES

Medical Marijuana, Inc. Appoints Squar Milner LLP As New Independent Auditor

  • By PR Newswire
  • Feb 18, 2020 9:00 AM EST
PRESS RELEASES

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion Of NIH-NIDA Phase 1 Grant And Results From Temple University

  • By PR Newswire
  • Feb 13, 2020 9:00 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.